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Abstract
Aims: The aim of the present study was to assess the ability of a potentially 
probiotic strain to resist, in vitro, the effect of intestinal antimicrobial 
molecules.
Methods and results: Strain CIDCA 133 of Lactobacillus delbrueckii subsp lactis 
was studied. Lactobacillus delbrueckii subsp bulgaricus as well as other gram­
positive and gram-negative bacteria were used for comparison purposes. The 
effect of different antimicrobial extracts was determined by diffusion assays, 
viable counts and growth kinetics. Human-defensins (h/(DI and h/>D2) were 
also included in the study. Two types of cellular fractions from Caco-2 cells 
were tested: (i) cytosolic fractions, obtained by sonication of cultured human 
enterocytes and (ii) cationic fraction, obtained by batch extraction of the cyto­
solic fraction with a weak cation exchange resin. In addition, the effect of 
Caco-2-secreted factors was studied. Strain CIDCA 133 was neither inhibited 
by Caco-2 secreted, cytosolic nor cationic fractions. Of note, human-defensins 
were inactive against strain CIDCA 133. In contrast, a related lactobacilli: 
Lactobacilli delbrueckii subsp bulgaricus (strain CIDCA 331) and other species 
of gram-positive or gram-negative bacteria were strongly inhibited.
Conclusions: Strain CIDCA 133 is able to survive and grow in the presence of 
enterocyte-derived antimicrobial molecules. This ability is not a general 
property of lactobacilli.
Significance and Impact of the Study: Results could provide a new insight into 
the mechanisms of the probiotic effect and encourage further studies on this 
field. Resistance to antimicrobial peptides can be relevant to understand the 
interaction of potentially probiotic strains with the host's immune system. This 
ability can be also relevant as a selection criterion for new probiotic strains.
Introduction
Probiotics are defined as ‘live microbial food supplements 
that improve the health of the host’ (Fuller 1989). Fer­
mented dairy products containing probiotic bacteria are 
the most successful category of functional foods (Saxelin 
et al. 2005). Lactobacilli and bifidobacteria are generally 
accepted as suitable candidates for the formulation of 
probiotics for humans. Consumption of probiotics 
positively affects the composition of intestinal microbiota 
and could provide several benefits for the host including 
the inhibition of intestinal pathogens, immunomodula­
tion, anticarcinogenic and antimutagenic activities, allevi­
ation of symptoms of lactose intolerance and reduction in 
serum cholesterol (Hord 2008). Selection criteria of 
potentially probiotic strains include several recommenda­
tions as technological adaptability, accurate identification, 
GRAS status and capacity to survive, proliferate and 
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develop their metabolic activity in vivo (Klaenhammer 
and Kullen 1999). Also, acid-bile tolerance and adherence 
to epithelial cells are considered as relevant characteristics 
in a probiotic strain (Mishra and Prasad 2005).
There are multiple factors that could affect the viability 
of probiotic micro-organisms in the gastrointestinal tract. 
The intestinal mucosa is protected from the attack of 
harmful enteric micro-organisms by host’s defences in the 
context of both adaptive and innate immunity. Innate 
immunity, the first line of defence, uses nonclonal recog­
nition molecules and nonspecific effector molecules. 
Epithelial cells are the main players of innate immunity 
by providing a physical barrier against bacterial translo­
cation as well as by producing several biologically active 
molecules. These factors, along with the resident micro­
biota, control pathogenic micro-organisms (Ganz 2002). 
The nonspecific effector molecules produced by the intes­
tinal epithelia include, mucins, enzymes, histones and 
antimicrobial peptides (AMPs) such as defensins (Hecht 
1999). These molecules could be either secreted to the 
extracellular milieu or remain in the cytoplasm and nuclei 
of the epithelial cells (Rose et al. 1998). AMPs are rela­
tively small proteins (12-100 amino acids), positively 
charged, amphiphillic, and they have a broad antimicro­
bial spectrum (Jenssen et al. 2006). Antimicrobial intesti­
nal peptides are produced by specialized cells (Paneth’s 
cells) and also by epithelial cells (Liévin-Le Moal and 
Servin 2006).
Human epithelial intestinal cells produce two types of 
AMPs: /J defensins (h/JD-1 and h/JD-2) and the cathelicidin 
hLL-37. At mucosal surfaces, AMPs can modify the balance 
of the colonizing microbiota (Salzman et al. 2007).
The aim of the present study was to assess the in vitro 
effect on potentially probiotic lactobacilli of antimicrobial 
factors present in cultured human enterocytes.
Materials and methods
Bacterial strains and growth conditions
Shigella flexneri, Escherichia coli CM1, Bacillus cereus M2 
and enteropathogenic Escherichia coli (EPEC) belong to 
the culture collection of the Cátedra de Microbiología of 
the Facultad de Ciencias Exactas (Universidad Nacional 
de La Plata, Argentine). Lactobacillus delbrueckii subsp. 
lactis strain CIDCA 133 and Lactobacillus delbrueckii 
subsp bulgaricus strain CIDCA 331 belong to the culture 
collection of the Centro de Investigación y Desarrollo 
en Criotecnología de Alimentos. (CIDCA, Facultad de 
Ciencias Exactas, Universidad Nacional de La Plata, 
Argentine). Stock cultures were stored at —80°C, and 
micro-organisms were reactivated twice in liquid medium 
before the experiments. Gram-negative bacteria were 
grown in nutrient broth (Biokar Diagnostics, Beauvais, 
France) at 37°C for 16 h. Bacillus cereus was cultured in 
Brain Heart Infusion (BHI) broth (Biokar Diagnostics, 
Beauvais, France) containing 01% (w/v) glucose at 32°C 
under orbital agitation. Incubation was performed for 3 h 
to obtain bacteria in early stationary phase thus minimiz­
ing the ratio of sporulated B. cereus. Lactobacilli were 
grown in de Man, Rogosa, Sharp (MRS) broth (Biokar 
Diagnostics, Beauvais, France) in anaerobic conditions at 
37°C for 16 h. Bacteria were harvested by centrifugation 
at 10 000 g for 10 min and suspended in phosphate 
buffered saline (PBS) or the appropriate growth medium.
Cell cultures
Caco-2 cells were cultured in 75-cm2 flasks (37°C, 5% 
CO2-95% air atmosphere) in Dulbecco’s Modified Eagle’s 
Medium (DMEM; Gibco BRL, Life Technologies, Rockville, 
MD, USA) supplemented with 10% (v/v) of foetal calf 
serum (PAA; Laboratories, GmbH, Pasching, Austria), 1% 
nonessential amino acids (Gibco, BRL, Life Technologies) 
and antibiotics (12 UI ml-1 penicillin and 12 ¿ig ml-1 
streptomycin). Monolayers at postconfluence (15 days of 
incubation) were used throughout. Forty-four hours before 
the experiments, Caco-2 cells were incubated in DMEM 
medium without neither foetal calf serum nor antibiotics 
to avoid the presence of inhibitory compounds other than 
those produced by the epithelial cells.
Caco-2-secreted factors
After the incubation of cell monolayers with DMEM 
without foetal calf serum nor antibiotics, spent culture 
supernatant was collected, lyophilized and suspended in 
distilled water to obtain ten-fold concentrated extracts. 
Samples were stored at —20°C until use.
Caco-2 cytosolic and brush border extracts
Cytosolic fractions were obtained according to the protocol 
of Pinto et al. (1983). Briefly, cells were collected and 
washed thrice using cold PBS. Then, they were suspended 
in Tris-Manitol buffer (2 mmol I-1 Tris, 50 mmol I-1 
manitol, pH 71). Afterwards, cell suspensions were 
incubated on ice and sonicated thrice for 30 s in an Ultra­
sonic Desintegrator, (Model 60 w; MSE Ltd., USA) The 
lysate was incubated with CaCl2 (10 mmol I-1) for 10 min 
at 4°C and centrifuged at 950 g for 10 min. Resulting 
supernatant was centrifuged at 33 500 g for 30 min at 4°C. 
After this step, two fractions were obtained: supernatant 
(cytosolic fraction) and pellet (brush border fraction). 
Cytosolic fraction was concentrated (ten-fold) by lyophi­
lization as described earlier.
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Batch extraction of the cationic fraction from cytosol
Batch extraction was used to concentrate the cationic 
fraction from cytosol (Porter et al. 1998). Cytosolic frac­
tion was incubated with a weak cation exchange resin 
(Macro-Prep CM; Bio-Rad Laboratories, CA, USA) at a 
ratio of 1 : 200 (resin : sample). After being incubated 
overnight at 4°C with gentle stirring, the resin was sepa­
rated by centrifugation (1500 g, 5 min). Afterwards, three 
washes with sodium phosphate buffer (10 mmol I-1) were 
performed. Adsorbed cations were eluted at 4°C by two 
steps of acid treatment i.e. 1 h in 10% (v/v) acetic acid 
and overnight in 5% (v/v) acetic acid. Supernatants 
collected from both extractions were pooled, concentrated 
by lyophilization and stored at -20°C until use.
Inhibition assays
Diffusion assays.
Antimicrobial activity of Caco-2 extracts was determined 
by using a diffusion assay as described by Lehrer 
et u/. (1991). Briefly, solid media were obtained by adding 
1% (w/v) agarose to nutrient or MRS broth. Bacterial 
suspensions (1 X 108 CFU ml-1) were spread on the sur­
face of solid medium by using a cotton swab. Afterwards, 
10 of samples was added to wells (2 5 mm in diameter) 
performed in the agarose. Plates were incubated for 24 h 
at 37°C, and zone diameters were measured.
Assays in liquid media.
To assess the effect of inhibitory factors on the growth 
kinetics of the strains under study, Caco-2 extracts or 
human /Ldefensins (h/iDI and h/?D2; Sigma-Aldrich Co., 
St Louis, MO, USA) were added to bacterial suspensions 
(1 X 105 CFU ml-1) in MRS or nutrient broth. /Ldefen­
sins were used at 0 5 qg ml-1. The number of surviving 
bacteria was determined by plating appropriate dilutions 
on either nutrient or MRS agar.
Statistical analysis
Results were compared by means of the two-tailed 
Student’s f-test using InfoStat Software (Grupo InfoStat, 
FCA, Universidad Nacional de Córdoba, Argentina).
Figure 1 Effect of cytosolic and brush border fractions derived from 
Caco-2 cells on different bacterial strains. Antimicrobial activity was 
determined by diffusion assays (agarose). Micro-organisms were 
incubated with cytosolic fraction (black bars), brush border fraction 
(striped bars) or phosphate buffered saline (PBS) (white bars). Data 
represent the means of zone diameters ± standard deviation (n = 3). 
Asterisks indicate significant differences with the corresponding PBS 
control (P < 0-05). Internal diameter of the wells was 2-5 mm.
or the brush border fraction with different bacteria 
revealed an inhibitory effect. The antagonism was 
observed both on gram-positive and gram-negative bacte­
ria (Fig. 1). Of note, whereas Shigella flexneri was strongly 
inhibited by both cytosolic and brush border fractions 
(zone diameters 14 5 ± 2 2 and 11 1 ± 14 mm, respec­
tively), enteropathogenic E. coli (EPEC) was only inhib­
ited by the cytosolic fraction (zone diameter 
7 0 ± 1-4 mm). Interestingly, L. delbrueckii subsp lactis 
CIDCA 133 was not antagonized neither by the cytosolic 
nor the brush border extract from Caco-2 cells. In 
contrast, the related micro-organism Lactobacillus del­
brueckii subsp bulgaricus strain CIDCA 331 was strongly 
inhibited by the cytosolic fraction. In addition, ten-fold 
concentrated spent culture supernatants from Caco-2 cells 
were assayed. Even though inhibition zones of 13 ± 1 
mm and 14 ± 1 mm were observed for strains 331 and 
CM1, respectively, no inhibition on strain 133 was 
detected (zone diameter 2 5 ± 0 0 mm).
It is worth noting that assays performed by using agar, 
instead of agarose, as the solidifying agent led to smaller 
zone diameters (data not shown).
Results
Effect of Caco-2 extracts on micro-organisms
To investigate the effect on different micro-organisms of 
cellular fractions obtained from Caco-2 cells, diffusion 
assays were conducted in culture media solidified with 
agarose. Incubation of either the Caco-2 cytosolic fraction
Characterization of the inhibitory activity
To distinguish between bacteriostatic and bactericidal 
activities, we performed assays in liquid medium. As 
shown in Fig. 2, incubation of E. coli CM1 with cytosolic 
fraction from Caco-2 cells led to a 3-log reduction in 
bacterial viability after 3-h incubation. This bactericidal 
effect was also observed for strain 331. Indeed, after 3-h
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Figure 2 Killing effect of cytosolic fraction extract from Caco-2 cells 
against Escherichia coli strain CM1. Results show a representative 
kinetics. (A) cytosolic extract, (O) control.
Table 1 Comparison of the effect on different micro-organisms of 
cytosolic and cationic extracts from Caco-2 cells
Strain
Cytosolic 
extract
Cationic 
extract
Escherichia coli C M1 ++ +
Bacillus cereus M2 ++ +
Lactobacillus delbrueckii subsp + +
bulgaricus (CIDCA 331)
Lactobacillus delbrueckii subsp - -
lactis (CIDCA 133)
Results are scored according to the size of zone diameter in the diffu­
sion assay. (+) 5-10 mm of inhibition zone; (++) 11-20 mm; (-) 
indicates no inhibitory effect (2-5 mm corresponding to the diameter 
of the well).
incubation with cytosolic extracts, viable counts of strain 
331 decreased from 104 CFU ml-1 to 103 CFU ml-1.
The findings that zone diameters in diffusion assays 
performed with agarose were larger than those obtained 
in agar-containing media, prompted us to investigate the 
role of cationic compounds in the inhibitory effect. To 
this end, we performed batch extraction of the cytosolic 
fraction from Caco-2 cells with a weak cation exchange 
resin. As given in Table 1, cationic fractions from Caco-2 
cells showed similar inhibition pattern that cytosolic 
extracts.
Effect of human /1-defensins
Even though several positively charged molecules (e.g. hi­
stones, phospholipase A2, defensins) could be present in 
the cationic extracts, the fact that human beta-defensins 
(h/iDs) are the most abundant antimicrobial peptides in
Time (h)
Figure 3 Growth curves of lactobacilli in the presence of human 
/Fdefensins. Symbols: (•, O) control; (A, A) h/JD-,; (O, ♦) 6/ÏD2. 
White symbols correspond to strain CIDCA 133, and black symbols 
correspond to strain CIDCA 331.
epithelial cells (Yanagi et al. 2007), prompted us to study 
the effect of purified human defensins.
Growth kinetics of lactobacilli performed in the pres­
ence of human /J-defensins (h/JDj and h/JD2) showed that 
whereas Lactobacillus delbrueckii subsp bulgaricus CIDCA 
331 was inhibited by both defensins (mainly by h/JD2), 
growth kinetics of Lactobacillus delbrueckii subsp lactis 
CIDCA 133 was not modified by defensins (Fig. 3). No 
effects were observed on the growth of E. coli CM1 in the 
presence of human defensins (data not shown).
Discussion
Survival of probiotic micro-organisms in the gastrointesti­
nal tract depends on the ability to cope with several 
antimicrobial molecules produced by different cell popu­
lations.
Caco-2 cells constitute a widely accepted model for the 
study of the interaction between micro-organisms and cell 
populations relevant to the defence mechanisms of the 
intestinal tract. It is known that Caco-2 cells are able to 
produce a set of molecules with antibacterial activity e. g. 
lysozyme, defensins, phospholipases and a-antitrypsin 
(Bernet-Camard et al. 1996; Ganz 2002). In the present 
study, we used Caco-2-derived extracts to assess the effect 
of such inhibitory molecules on intestinal bacteria.
Whereas cytosolic extracts were inhibitory to most of 
the strains under study, strains CIDCA 133 and entero- 
pathogenic E. coli (EPEC) showed a different behaviour, 
i.e. strain 133 was not inhibited, and EPEC was inhibited 
but in a lesser extent than other strains. This behaviour 
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could be expected for a pathogenic micro-organism 
(EPEC), but, surprisingly, a nonpathogenic and poten­
tially probiotic micro-organism such as strain CIDCA 133 
was also able to resist the inhibitory effect of Caco-2- 
derived factors. Furthermore, a different Lactobacillus 
strain was strongly inhibited by cytosolic extracts (Fig. 1). 
Noteworthy, concentrated spent supernatants from Caco- 
2 cell cultures inhibited both E. coli CM1 and L. del- 
breuckii subsp bulgaricus CIDCA 331, thus indicating that, 
in contrast to strain 133, these strains would not be active 
in the presence of secreted factors from enterocytes.
Defensins as well as other cationic molecules with anti­
bacterial activity are important effectors of the innate 
immune system. Strain CIDCA 133 was resistant not only 
to the effect of the Caco-2 cationic extract but also to 
purified human /i defensins (Table 1, Fig. 3).
The observed effect depends on the defensin/bacteria 
ratio. Indeed, when 103 CFU ml-1 was incubated for 
24 h with different concentrations of human /J-defensins, 
we found that strains CM1 and 133 were able to grow 
in the presence of 5 and 2 5 pg ml-1 of human beta- 
defensins, respectively, whereas strain 331 is able to grow 
at the concentrations of 0 08 pg ml-1 hBD (data not 
shown). It is worth noting that concentration of 
h/JD2 in human faeces ranges from 0 01 to 0 06 pg ml-1 
(Mondel et al. 2009).
Antimicrobial peptides (AMPs) lead to antimicrobial 
effect by damaging or destabilizing cytoplasmic mem­
brane or acting at cytoplasmic level by inhibiting essential 
cellular process such as protein or nucleic acid synthesis 
(Brogden 2005). Regardless of their precise mode of 
action, the activities of AMPs are almost universally 
dependent upon interaction with the bacterial cell mem­
brane (Hancock and Rozek 2002). Interactions between 
antimicrobial peptides and bacteria are determined by 
electrostatic attraction between the positive-charged 
AMPs and anionic bacterial structures such as lipids and 
other surface structures (Jenssen et al. 2006).
Bacterial pathogens have evolved mechanisms to limit 
the effectiveness of AMPs. These mechanisms involve the 
diminution of the electrostatic interaction between AMPs 
and bacterial surface by reducing the net negative charge 
of the bacterial cell envelope through the covalent modifi­
cation of anionic molecules such as lipid A, teichoic acids 
or phospholipids (Peschel 2002).
As strain CIDCA 133 was affected neither by the cat­
ionic extract from Caco-2 cells nor by purified human /J 
defensins, whereas strain CIDCA 331 was strongly inhib­
ited, we could hypothesize that these strains differ in the 
composition of lipids or teichoic acids. In fact, chromato­
graphic analysis revealed the different proportions of fatty 
acids present in cellular lipids between the two strains 
(Gomez Zavaglia et al. 2000).
The ability of probiotic micro-organisms to induce the 
production of antimicrobial molecules has been reported. 
Indeed, probiotic bacteria provoked a strong induction of 
h/JD2 synthesis in intestinal epithelial cells Caco-2 (Schlee 
et al. 2007, 2008). Furthermore, in vivo studies demon­
strated that oral administration of potentially probiotic 
E. coli strains increases faecal secretion of h/JD2 in healthy 
volunteers (Mondel et al. 2009). It is worth noting that 
this probiotic strain was not resistant to the induced anti­
microbial factors such as h/JD2. These findings could 
indicate the possibility of a suicidal character of this 
interaction (Mondel et al. 2009).
Lactobacillus delbrueckii subsp lactis CIDCA 133 dem­
onstrated the ability to antagonize biological effect of 
enterohaemorrhagic E. coli (EHEC) in vitro and to inhibit 
nitrate reductase activity of a nonpathogenic commensal 
E. coli strain (Hugo et al. 2006, 2008). In the present 
study, we showed the ability of this strain to resist the 
effects of antimicrobial factors derived from cultured 
human enterocytes as well as to overcome the inhibitory 
effect of human /J defensins. These findings could be 
relevant to predict the competitiveness of this strain 
in vivo and to understand the interaction of selected 
probiotic micro-organisms with host's cells and the 
resulting immune response.
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